MAPT and Alzheimer disease: Remarkably, our results demonstrated that organoids exposed to AD brain extracts successfully recapitulated multiple AD-like pathologies, including Aβ plaque-like aggregates, tau tangle-like aggregates, neuroinflammation, elevated microglial synaptic pruning, synapse/neuronal loss, but not organoids treated with vehicle control.